The thienopyridine class of antiplatelet drugs

Zane Kaplan, Saheb Al-Daher, Hatem H. Salem

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.

Original languageEnglish
Pages (from-to)65-70
Number of pages6
JournalMedicine Today
Volume11
Issue number8
Publication statusPublished - Aug 2010

Cite this

Kaplan, Zane ; Al-Daher, Saheb ; Salem, Hatem H. / The thienopyridine class of antiplatelet drugs. In: Medicine Today. 2010 ; Vol. 11, No. 8. pp. 65-70.
@article{5fec39f2b2434cbca3d8e649c0462024,
title = "The thienopyridine class of antiplatelet drugs",
abstract = "The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.",
author = "Zane Kaplan and Saheb Al-Daher and Salem, {Hatem H.}",
year = "2010",
month = "8",
language = "English",
volume = "11",
pages = "65--70",
journal = "Medicine Today",
issn = "1443-430X",
publisher = "Medicine Today",
number = "8",

}

The thienopyridine class of antiplatelet drugs. / Kaplan, Zane; Al-Daher, Saheb; Salem, Hatem H.

In: Medicine Today, Vol. 11, No. 8, 08.2010, p. 65-70.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - The thienopyridine class of antiplatelet drugs

AU - Kaplan, Zane

AU - Al-Daher, Saheb

AU - Salem, Hatem H.

PY - 2010/8

Y1 - 2010/8

N2 - The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.

AB - The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.

UR - http://www.scopus.com/inward/record.url?scp=77955816998&partnerID=8YFLogxK

M3 - Review Article

VL - 11

SP - 65

EP - 70

JO - Medicine Today

JF - Medicine Today

SN - 1443-430X

IS - 8

ER -